tiprankstipranks
Quick Heal Technologies Ltd. (IN:QUICKHEAL)
:QUICKHEAL
India Market
Want to see IN:QUICKHEAL full AI Analyst Report?

Quick Heal Technologies Ltd. (QUICKHEAL) AI Stock Analysis

2 Followers

Top Page

IN:QUICKHEAL

Quick Heal Technologies Ltd.

(QUICKHEAL)

Select Model
Select Model
Select Model
Neutral 46 (OpenAI - 5.2)
Rating:46Neutral
Price Target:
₹188.00
▼(-30.06% Downside)
Action:Reiterated
Date:06/03/26
The score is mainly held back by weakening fundamentals (declining revenue, swing into losses, and inconsistent cash generation). Technicals also remain soft with the stock below key moving averages, while valuation is difficult to support because the company is loss-making and dividend yield data is unavailable.
Positive Factors
Balance sheet strength
Near-zero debt and a substantial equity buffer give the company durable financial flexibility. This lowers interest burden risk, supports sustained R&D and product investment through downturns, and provides a capital cushion to pursue strategic initiatives without immediate financing.
Negative Factors
Declining revenue trend
Consecutive annual revenue declines signal weakening demand or competitive erosion. Persistent top-line contraction hampers operating leverage, limits funds available for product investment, and makes margin recovery harder, risking a prolonged rebuilding period to regain growth momentum.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance sheet strength
Near-zero debt and a substantial equity buffer give the company durable financial flexibility. This lowers interest burden risk, supports sustained R&D and product investment through downturns, and provides a capital cushion to pursue strategic initiatives without immediate financing.
Read all positive factors

Quick Heal Technologies Ltd. (QUICKHEAL) vs. iShares MSCI India ETF (INDA)

Quick Heal Technologies Ltd. Business Overview & Revenue Model

Company Description
Quick Heal Technologies Limited, an Indian company established in Pune in 1995, specializes in providing cybersecurity software and solutions. The firm caters to a diverse clientele, including individual consumers, small and medium-sized businesse...
How the Company Makes Money
Quick Heal Technologies makes money primarily by selling cybersecurity software and related services under its consumer (Quick Heal) and enterprise (Seqrite) product lines. Key revenue streams generally include: (1) consumer cybersecurity licenses...

Quick Heal Technologies Ltd. Financial Statement Overview

Summary
Operational performance is weak: revenue has been declining (down ~4% in FY2025 and ~6% in FY2026) and profitability deteriorated into operating losses, with a net loss in FY2026. The balance sheet is a clear strength with near-zero debt and a solid equity buffer, but cash flow quality is inconsistent (negative OCF/FCF in FY2025 and only near-breakeven FCF in FY2026).
Income Statement
34
Negative
Balance Sheet
82
Very Positive
Cash Flow
46
Neutral
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue2.77B2.61B2.80B2.92B2.78B3.42B
Gross Profit2.72B599.40M2.72B1.17B1.14B1.92B
EBITDA78.90M-293.70M-65.90M373.00M227.70M1.07B
Net Income-7.40M-109.30M50.40M242.40M64.00M831.90M
Balance Sheet
Total Assets5.45B5.47B5.25B5.13B4.93B7.16B
Cash, Cash Equivalents and Short-Term Investments1.85B2.18B1.93B2.20B1.88B3.54B
Total Debt0.001.10M3.10M0.000.000.00
Total Liabilities988.80M1.10B835.60M756.30M735.90M882.50M
Stockholders Equity4.46B4.37B4.41B4.37B4.20B6.28B
Cash Flow
Free Cash Flow-189.90M4.10M-367.20M106.30M267.30M741.30M
Operating Cash Flow-54.30M158.30M-223.00M181.90M308.10M799.80M
Investing Cash Flow-102.90M-261.80M159.70M61.50M1.85B1.26B
Financing Cash Flow16.20M27.60M-103.20M16.00M-2.12B-2.14B

Quick Heal Technologies Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
₹6.77B19.665.97%18.36%0.03%
72
Outperform
₹38.79B35.650.21%35.08%26.95%
62
Neutral
₹8.07B9.5510.85%7.23%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
60
Neutral
₹5.95B20.32-2.29%
46
Neutral
₹9.15B-86.951.08%-6.62%-303.63%
42
Neutral
₹636.14M-0.41-62.43%-1029.62%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:QUICKHEAL
Quick Heal Technologies Ltd.
168.70
-200.70
-54.33%
IN:EMUDHRA
eMudhra Limited
468.45
-269.01
-36.48%
IN:KELLTONTEC
Kellton Tech Solutions Ltd.
15.29
-10.74
-41.26%
IN:KSOLVES
Ksolves India Ltd
285.30
-47.79
-14.35%
IN:SECURKLOUD
SecureKloud Technologies Limited
19.04
-5.46
-22.29%
IN:SUBEXLTD
Subex Limited
10.58
-4.40
-29.37%

Quick Heal Technologies Ltd. Corporate Events

Exchange Seeks Clarification From Quick Heal After Sharp Stock Move
May 11, 2026
The stock of Quick Heal Technologies Limited has shown significant price movement, prompting the exchange to seek updated, relevant information from the company. The exchange’s action underscores a focus on safeguarding investor interests an...
Quick Heal Allots 2,261 ESOP Shares, Slightly Expands Equity Base
Apr 27, 2026
Quick Heal Technologies has allotted 2,261 equity shares under its ESOP Scheme 2021 following the exercise of employee stock options, marginally increasing its total issued equity share capital. The new shares, issued at various exercise prices wi...
Quick Heal Closes Trading Window Ahead of FY 2026 Results
Mar 23, 2026
Quick Heal Technologies Limited has announced that its trading window for dealing in the company’s securities will be closed from April 1, 2026, in line with SEBI’s Prohibition of Insider Trading Regulations, 2015, and its internal cod...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 03, 2026